Nigel S. Baber

1.1k total citations · 1 hit paper
16 papers, 912 citations indexed

About

Nigel S. Baber is a scholar working on Pediatrics, Perinatology and Child Health, Economics and Econometrics and Pharmacology. According to data from OpenAlex, Nigel S. Baber has authored 16 papers receiving a total of 912 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pediatrics, Perinatology and Child Health, 4 papers in Economics and Econometrics and 3 papers in Pharmacology. Recurrent topics in Nigel S. Baber's work include Pharmaceutical studies and practices (7 papers), Pharmaceutical Economics and Policy (3 papers) and Pharmaceutical Practices and Patient Outcomes (3 papers). Nigel S. Baber is often cited by papers focused on Pharmaceutical studies and practices (7 papers), Pharmaceutical Economics and Policy (3 papers) and Pharmaceutical Practices and Patient Outcomes (3 papers). Nigel S. Baber collaborates with scholars based in United Kingdom, Netherlands and United States. Nigel S. Baber's co-authors include Colin T. Dourish, David R. Hill, Stuart H. Ellis, Matthew A. Brown, Evan J. Begg, Peter Stonier, M. S. Lennard, Lionel D. Lewis, Jeffrey K Aronson and J C Mucklow and has published in prestigious journals such as Pain, British Journal of Clinical Pharmacology and Biopharmaceutics & Drug Disposition.

In The Last Decade

Nigel S. Baber

16 papers receiving 876 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use (ICH).

1994 621 citations Nigel S. Baber British Journal of Clinical Pharmacology profile →

Peers

Nigel S. Baber

PHYSI

CMN

MB

PPCH

PHEOH

Charles Locke United States

Hsiang‐Yin Chen Taiwan

Caterina Palleria Italy

Yuji Kurosaki Japan

Hazem E. Hassan United States

AF Lant United Kingdom

Jesús Frías Spain

Harmanjit Singh India

Eduardo Barbosa Coelho Brazil

Keith Burkhart United States

Charles Locke United States

Nigel S. Baber

189 ×1.0

PHYSI

93 ×0.5

CMN

192 ×1.2

MB

156 ×1.3

PPCH

60 ×0.7

PHEOH

Citations per year, relative to Nigel S. Baber Nigel S. Baber (= 1×) peers Charles Locke

Countries citing papers authored by Nigel S. Baber

Since Specialization

Citations

This map shows the geographic impact of Nigel S. Baber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nigel S. Baber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nigel S. Baber more than expected).

Fields of papers citing papers by Nigel S. Baber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nigel S. Baber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nigel S. Baber. The network helps show where Nigel S. Baber may publish in the future.

Co-authorship network of co-authors of Nigel S. Baber

This figure shows the co-authorship network connecting the top 25 collaborators of Nigel S. Baber. A scholar is included among the top collaborators of Nigel S. Baber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nigel S. Baber. Nigel S. Baber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

1.

Baber, Nigel S.. (2007). Guide to Paediatric Clinical Research. British Journal of Clinical Pharmacology. 65(2). 282–282. 16 indexed citations

2.

Aronson, Jeffrey K, et al.. (2006). Editors’ Report 2005. British Journal of Clinical Pharmacology. 61(5). 492–493. 2 indexed citations

3.

Baber, Nigel S.. (2005). Tripartite meeting. Paediatric regulatory guidelines: do they help in optimizing dose selection for children?. British Journal of Clinical Pharmacology. 59(6). 660–662. 5 indexed citations

4.

Aronson, Jeffrey K, M. S. Lennard, James M. Ritter, et al.. (2005). Today's science, tomorrow's medicines. British Journal of Clinical Pharmacology. 61(1). 1–4. 1 indexed citations

5.

Baber, Nigel S.. (2005). Paediatric special issue. British Journal of Clinical Pharmacology. 59(6). 651–654. 3 indexed citations

6.

Aronson, Jeffrey K, et al.. (2005). Editors’ Report 2004. British Journal of Clinical Pharmacology. 60(1). 5–6. 1 indexed citations

7.

Baber, Nigel S., et al.. (2003). Dose estimation for children. British Journal of Clinical Pharmacology. 56(5). 489–493. 22 indexed citations

8.

Mucklow, J C, Nigel S. Baber, Simon Maxwell, & Munir Pirmohamed. (2003). The BPS web site for Continuing Professional Development in Clinical Pharmacology and Therapeutics. British Journal of Clinical Pharmacology. 56(4). 349–350. 1 indexed citations

9.

Baber, Nigel S.. (2003). Complementary medicines, clinical pharmacology and therapeutics. British Journal of Clinical Pharmacology. 55(3). 225–225. 4 indexed citations

10.

Stonier, Peter & Nigel S. Baber. (2000). Clinical pharmacology and the Faculty of Pharmaceutical Medicine. British Journal of Clinical Pharmacology. 49(6). 523–524. 1 indexed citations

11.

Baber, Nigel S., et al.. (1997). The Clinical Section of the British Pharmacological Society: prospects for the future. British Journal of Clinical Pharmacology. 44(3). 215–218. 1 indexed citations

12.

Baber, Nigel S. & Matthew A. Brown. (1996). A new opportunity for training in Clinical Pharmacology. British Journal of Clinical Pharmacology. 41(5). 365–368. 4 indexed citations

13.

Baber, Nigel S.. (1994). International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use (ICH).. British Journal of Clinical Pharmacology. 37(5). 401–404. 621 indexed citations breakdown →

14.

Baber, Nigel S., Colin T. Dourish, & David R. Hill. (1989). The role of CCK, caerulein, and CCK antagonists in nociception. Pain. 39(3). 307–328. 205 indexed citations

15.

Baber, Nigel S., et al.. (1981). Bioavailability of sustained release propranolol formulations. Biopharmaceutics & Drug Disposition. 2(1). 39–48. 21 indexed citations

16.

Baber, Nigel S., et al.. (1981). Bioavailability of propranolol and bendrofluazide formulations. Biopharmaceutics & Drug Disposition. 2(2). 167–175. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact